THE BUSINESS OF BIOTECH
A New Prescription For PBMs with Allan Shaw
Back by popular demand, biopharma industry opinionator extraordinaire Allan Shaw rejoins the Business of Biotech to expose the murky role Pharmacy Benefit Managers (PBMs) play in the last, costly mile of the drug distribution supply chain. Allan pulls no punches in his criticism of the current rebate structure and shares why the model leaves patients and manufacturers stuck with the spiraling tab.
ABOUT THE BUSINESS OF BIOTECH
Created exclusively for the leaders of new and emerging biopharma firms, The Business of Biotech tackles organizational, funding, HR, regulatory, production and CMC considerations with insight from peer founders who have taken biologic therapies from an idea to clinical success.
FEATURED GUESTS
Yochi Slonim
Thomas Barnes
Rahul Kakkar
Bobby Reddy
Jason Gardner
Karen Harris
Michael Nally
Gavin Samuels
Robert Williamson
MEET THE HOST
Hosted by Bioprocess Online Chief Editor Matt Pillar, The Business of Biotech brings you weekly intelligence and insight, from leading voices in the biotech industry.
Interested in joining us on air ? Contact us
RECENT EPISODES
FINANCE & CAPITAL MARKETS
Origins Of A Biopharma VC Deal With Bernat Olle, Ph.D. And Parag Shah
IL-2 Program Profits With Bonum's Drs. John Mulligan And Neela Patel
DISCOVERY
REGULATORY
MANUFACTURING
Antibody-Cytokine Combinations With Philogen's Dr. Dario Neri
CDMO Collab with Scorpius BioManufacturing's Steve Lavezoli + Fina Biosolutions' Dr. Andrew Lees
Building A Better COVID Vaccine With Ocugen's Shankar Musunuri, Ph.D.
mAb Manufacturing with Rezolute Bio's Nevan Charles Elam, JD
Cell Therapy Platform Dev With Precigen CEO Dr. Helen Sabzevari
Peptides & Proteins: Resetting The Immune System With Revolo CEO Jonathan Rigby